(FTV) Fortive - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US34959J1088

Sensors, Instruments, Sterilizers, Tracking, Biomedical

FTV EPS (Earnings per Share)

EPS (Earnings per Share) of FTV over the last years for every Quarter: "2020-09": 0.94, "2020-12": 0.7, "2021-03": 0.63, "2021-06": 0.66, "2021-09": 0.66, "2021-12": 0.79, "2022-03": 0.7, "2022-06": 0.78, "2022-09": 0.79, "2022-12": 0.88, "2023-03": 0.75, "2023-06": 0.85, "2023-09": 0.85, "2023-12": 0.98, "2024-03": 0.83, "2024-06": 0.93, "2024-09": 0.97, "2024-12": 1.17, "2025-03": 0.85, "2025-06": 0.58, "2025-09": 0.68,

FTV Revenue

Revenue of FTV over the last years for every Quarter: 2020-09: 1159.8, 2020-12: 1324.9, 2021-03: 1259.2, 2021-06: 1319.7, 2021-09: 1301, 2021-12: 1374.8, 2022-03: 1376.5, 2022-06: 1463.3, 2022-09: 1456, 2022-12: 1529.9, 2023-03: 1460.7, 2023-06: 1526.4, 2023-09: 1494.5, 2023-12: 1583.7, 2024-03: 1524.5, 2024-06: 1552.4, 2024-09: 1534.6, 2024-12: 1620.3, 2025-03: 1474.2, 2025-06: 1518.8, 2025-09: 1027.099999,

Description: FTV Fortive October 30, 2025

Fortive Corp (NYSE:FTV) designs, develops, manufactures, and markets a broad portfolio of products, software, and services across the United States, China, and other international markets. The company is organized into two operating segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). IOS delivers instrumentation, test-and-measurement equipment, lifecycle-management software, and connected-worker safety tools for industries ranging from manufacturing to utilities, under brands such as FLUKE, GORDIAN, and PRUFTECHNIK. AHS focuses on critical workflow solutions for the healthcare sector, including instrument sterilization, cell-therapy equipment, radiation detection, and clinical productivity software, marketed under names like STERRAD, LANDAUER, and FLUKE BIOMEDICAL.

Key performance indicators from the most recent fiscal year (FY 2023) show total revenue of approximately $5.5 billion, with the AHS segment growing ~8 % YoY, outpacing the IOS segment’s modest 3 % increase. Operating margin hovered around 12 %, reflecting continued cost-discipline despite inflationary pressure on component costs. The industrial automation trend-driven by rising demand for digital twins and predictive maintenance-remains a primary growth catalyst for IOS, while an aging global population and expanding outpatient care settings underpin AHS demand for sterilization and workflow solutions.

Given Fortive’s diversified end-markets and steady cash-flow generation, analysts often monitor its free-cash-flow conversion (historically > 80 %) and capital-allocation strategy, especially the balance between dividend payouts and share-repurchase programs. For a deeper dive into Fortive’s valuation metrics and comparable peers, you may find ValueRay’s analyst toolkit useful.

FTV Stock Overview

Market Cap in USD 16,278m
Sub-Industry Industrial Machinery & Supplies & Components
IPO / Inception 2016-07-01

FTV Stock Ratings

Growth Rating -23.6%
Fundamental 52.2%
Dividend Rating 48.9%
Return 12m vs S&P 500 -20.9%
Analyst Rating 3.85 of 5

FTV Dividends

Dividend Yield 12m 0.57%
Yield on Cost 5y 0.56%
Annual Growth 5y 6.83%
Payout Consistency 98.5%
Payout Ratio 7.0%

FTV Growth Ratios

Growth Correlation 3m 76.7%
Growth Correlation 12m -81.3%
Growth Correlation 5y 26%
CAGR 5y 0.23%
CAGR/Max DD 3y (Calmar Ratio) 0.01
CAGR/Mean DD 3y (Pain Ratio) 0.02
Sharpe Ratio 12m -0.66
Alpha -23.73
Beta 1.128
Volatility 22.15%
Current Volume 3262.9k
Average Volume 20d 2453.3k
Stop Loss 49.6 (-3.2%)
Signal 0.36

Piotroski VR‑10 (Strict, 0-10) 8.5

Net Income (602.3m TTM) > 0 and > 6% of Revenue (6% = 338.4m TTM)
FCFTA 0.09 (>2.0%) and ΔFCFTA 1.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -13.08% (prev 8.63%; Δ -21.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.10 (>3.0%) and CFO 1.19b > Net Income 602.3m (YES >=105%, WARN >=100%)
Net Debt (2.88b) to EBITDA (1.39b) ratio: 2.07 <= 3.0 (WARN <= 3.5)
Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (333.4m) change vs 12m ago -5.36% (target <= -2.0% for YES)
Gross Margin 60.33% (prev 59.74%; Δ 0.59pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 38.45% (prev 35.50%; Δ 2.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 7.55 (EBITDA TTM 1.39b / Interest Expense TTM 122.6m) >= 6 (WARN >= 3)

Altman Z'' 2.49

(A) -0.06 = (Total Current Assets 1.73b - Total Current Liabilities 2.47b) / Total Assets 11.89b
(B) 0.44 = Retained Earnings (Balance) 5.26b / Total Assets 11.89b
(C) 0.06 = EBIT TTM 925.7m / Avg Total Assets 14.67b
(D) 0.99 = Book Value of Equity 5.30b / Total Liabilities 5.38b
Total Rating: 2.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.16

1. Piotroski 8.50pt = 3.50
2. FCF Yield 5.65% = 2.82
3. FCF Margin 19.18% = 4.80
4. Debt/Equity 0.51 = 2.37
5. Debt/Ebitda 2.07 = -0.15
6. ROIC - WACC (= -5.89)% = -7.36
7. RoE 6.46% = 0.54
8. Rev. Trend -42.10% = -3.16
9. EPS Trend -24.14% = -1.21

What is the price of FTV shares?

As of November 10, 2025, the stock is trading at USD 51.23 with a total of 3,262,904 shares traded.
Over the past week, the price has changed by +2.26%, over one month by +3.91%, over three months by +9.90% and over the past year by -10.23%.

Is Fortive a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Fortive is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 52.16 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FTV is around 45.48 USD . This means that FTV is currently overvalued and has a potential downside of -11.22%.

Is FTV a buy, sell or hold?

Fortive has received a consensus analysts rating of 3.85. Therefore, it is recommended to buy FTV.
  • Strong Buy: 6
  • Buy: 5
  • Hold: 9
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the FTV price?

Issuer Target Up/Down from current
Wallstreet Target Price 56.7 10.7%
Analysts Target Price 56.7 10.7%
ValueRay Target Price 50.7 -1%

FTV Fundamental Data Overview November 01, 2025

Market Cap USD = 16.28b (16.28b USD * 1.0 USD.USD)
P/E Trailing = 20.1772
P/E Forward = 18.3486
P/S = 2.6001
P/B = 1.6223
P/EG = 1.2896
Beta = 1.128
Revenue TTM = 5.64b USD
EBIT TTM = 925.7m USD
EBITDA TTM = 1.39b USD
Long Term Debt = 3.33b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.19b USD (from shortTermDebt, last quarter)
Debt = 3.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.88b USD (from netDebt column, last quarter)
Enterprise Value = 19.15b USD (16.28b + Debt 3.31b - CCE 430.8m)
Interest Coverage Ratio = 7.55 (Ebit TTM 925.7m / Interest Expense TTM 122.6m)
FCF Yield = 5.65% (FCF TTM 1.08b / Enterprise Value 19.15b)
FCF Margin = 19.18% (FCF TTM 1.08b / Revenue TTM 5.64b)
Net Margin = 10.68% (Net Income TTM 602.3m / Revenue TTM 5.64b)
Gross Margin = 60.33% ((Revenue TTM 5.64b - Cost of Revenue TTM 2.24b) / Revenue TTM)
Gross Margin QoQ = 63.21% (prev 58.97%)
Tobins Q-Ratio = 1.61 (Enterprise Value 19.15b / Total Assets 11.89b)
Interest Expense / Debt = 0.77% (Interest Expense 25.4m / Debt 3.31b)
Taxrate = 59.26% (80.0m / 135.0m)
NOPAT = 377.1m (EBIT 925.7m * (1 - 59.26%))
Current Ratio = 0.70 (Total Current Assets 1.73b / Total Current Liabilities 2.47b)
Debt / Equity = 0.51 (Debt 3.31b / totalStockholderEquity, last quarter 6.50b)
Debt / EBITDA = 2.07 (Net Debt 2.88b / EBITDA 1.39b)
Debt / FCF = 2.66 (Net Debt 2.88b / FCF TTM 1.08b)
Total Stockholder Equity = 9.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 602.3m / Total Assets 11.89b)
RoE = 6.46% (Net Income TTM 602.3m / Total Stockholder Equity 9.33b)
RoCE = 7.31% (EBIT 925.7m / Capital Employed (Equity 9.33b + L.T.Debt 3.33b))
RoIC = 2.62% (NOPAT 377.1m / Invested Capital 14.40b)
WACC = 8.51% (E(16.28b)/V(19.58b) * Re(10.17%) + D(3.31b)/V(19.58b) * Rd(0.77%) * (1-Tc(0.59)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.02%
[DCF Debug] Terminal Value 72.57% ; FCFE base≈1.19b ; Y1≈1.31b ; Y5≈1.69b
Fair Price DCF = 64.73 (DCF Value 20.56b / Shares Outstanding 317.6m; 5y FCF grow 11.56% → 3.0% )
EPS Correlation: -24.14 | EPS CAGR: -8.95% | SUE: 4.0 | # QB: 1
Revenue Correlation: -42.10 | Revenue CAGR: -13.49% | SUE: 0.11 | # QB: 0

Additional Sources for FTV Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle